Patients with melanoma brain metastases that have BRAF V600E alterations have worse outcomes, according to a new analysis appearing in JAMA Network Open.
2023
Immunotherapy Options for an Older Patient With Metastatic Melanoma
During a Targeted Oncology™ Case-Based Roundtable™ event, April K.S. Salama, MD, discussed treatment approaches for a 78-year-old patient with metastatic melanoma discovered 12 years after surgical resection.
Dr. Mehmi on Fianlimab and Cemiplimab in Patients with Poor-Risk, Advanced Melanoma
Inderjit Mehmi, MD, discusses results from a subgroup analysis of patients with advanced melanoma and poor-risk features given fianlimab and cemiplimab in a phase 1 trial.
Researchers Develop Potential Treatment For Deadliest Skin Cancer Using Modified Herpes Virus
A new phase II clinical trial consisting of the use of a modified herpes virus has yielded favourable results for a strategy against melanoma.